Form 3 - Initial statement of beneficial ownership of securities
July 10 2023 - 5:04PM
Edgar (US Regulatory)
Exhibit 24
POWER OF ATTORNEY
The undersigned constitutes and appoints PERRY C. SIATIS, EMILY A.
WEITH, and T.O. ODUTAYO, and each of them individually, as the undersigned's true and lawful attorney-in-fact and agent, with full power
of substitution and re-substitution, for the undersigned and in the undersigned's name, place and stead, to prepare and sign any and all
Securities and Exchange Commission ("SEC") Notices of Proposed Sales of Securities pursuant to Rule 144 under the Securities
Act of 1933 on Form 144, all SEC statements on Forms 3, 4 and 5 as required under Section 16(a) of the Securities Exchange
Act of 1934, including a Form ID and any other documents necessary to obtain codes and passwords necessary to make electronic filings,
and any amendments or successors to such forms, and to file the same with all exhibits thereto, and other documents in connection therewith,
with the SEC, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite, necessary
or desirable to be done under said Rule 144 and Section 16(a), as fully for all intents and purposes as the undersigned might
or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent may lawfully do or cause to be done by
virtue hereof.
A copy of this power of attorney shall be filed with the SEC. The
authorization set forth above shall continue in full force and effect until the undersigned is no longer required to file Forms 144,
3, 4, or 5 or if earlier, until the undersigned revokes such authorization by written instructions to the attorney-in-fact.
Date:
June 28, 2023 |
|
|
|
/s/
Nicholas J. Donoghoe |
|
Signature
of Reporting Person |
|
|
|
Nicholas
J. Donoghoe |
|
Name |
|
|
|
AbbVie
Inc. |
|
1
N. Waukegan Road |
|
North
Chicago, IL 60064 |
|
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Sep 2024 to Oct 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Oct 2023 to Oct 2024